Skip to main content

Table 5 Mean arterial blood pressure expressed in mmHg in the three study groups

From: Acute hypervolemic hemodilution combined with controlled hypotension to minimize blood loss during operations of spine fusion: remifentanil versus magnesium sulfate

 

Group I

(N = 18)

Group II

(N = 20)

Group III

(N = 19)

p value

Baseline (before induction)

96.1 ± 12.2

94.2 ± 11.2

97.8 ± 10.5

0.619

5 min after AHH start

93.1 ± 11.3

88.7 ± 10.8

88.6 ± 11.7

0.242

10 min after AHH start

89.6 ± 10.9

87.0 ± 9.5

84.9 ± 10.1

0.439

15 min after AHH start

90.3 ± 11.1

68.6 ± 10.6*+

75.4 ± 9.8*

< 0.001

30 min after AHH start

89.8 ± 12.1

69.2 ± 11.4*

69.4 ± 10.6*

< 0.001

45 min after AHH start

86.7 ± 9.9

68.8 ± 10.3*

67.2 ± 11.1*

< 0.001

60 min after AHH start

87.9 ± 10.4

68.9 ± 9.1*

67.8 ± 9.9*

< 0.001

90 min after AHH start

85.6 ± 9.8

66.7 ± 11.1*

66.4 ± 10.2*

< 0.001

2 h after AHH start

86.7 ± 11.6

66.3 ± 10.7*

66.7 ± 12.5*

< 0.001

3 h after AHH start

84.4 ± 12.3

67.7 ± 12.2*

69.6 ± 11.6*

< 0.001

  1. -Data are presented as mean ± SD. p < 0.05 is considered significant.
  2. -*Significant in group II or group III in relation to group I
  3. -+Significant in group II in relation to group III